In the last trading session, 1.43 million Acelyrin Inc (NASDAQ:SLRN) shares changed hands as the company’s beta touched 0.93. With the company’s per share price at $2.23 changed hands at -$0.02 or -0.89% during last session, the market valuation stood at $225.13M. SLRN’s last price was a discount, traded about -225.11% off its 52-week high of $7.25. The share price had its 52-week low at $1.85, which suggests the last value was 17.04% up since then.
Analysts gave the Acelyrin Inc (SLRN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 14 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 5 recommended SLRN as a Hold, 9 felt it is a Buy and 0 rated the stock as Underweight.
Acelyrin Inc (NASDAQ:SLRN) trade information
Instantly SLRN was in red as seen at the end of in last trading. With action -10.08%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -28.98%, with the 5-day performance at -10.08% in the red. However, in the 30-day time frame, Acelyrin Inc (NASDAQ:SLRN) is 1.36% up.
The consensus price target for the stock as assigned by Wall Street analysts is 10.5, meaning bulls need an upside of 78.76% from its current market value. According to analyst projections, SLRN’s forecast low is 6 with 15 as the target high. To hit the forecast high, the stock’s price needs a -572.65% plunge from its current level, while the stock would need to soar -169.06% for it to hit the projected low.
Acelyrin Inc (NASDAQ:SLRN)’s Major holders
CITADEL ADVISORS LLC holds the second largest percentage of outstanding shares, with 7.4732% or 7.41 million shares worth $32.68 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were T. Rowe Price Small-Cap Stock Fund, Inc. and T. Rowe Price Small-Cap Value Fund, Inc. With 3.63 shares estimated at $8.08 million under it, the former controlled 3.59% of total outstanding shares. On the other hand, T. Rowe Price Small-Cap Value Fund, Inc. held about 2.81% of the shares, roughly 2.84 shares worth around $6.33 million.
